Dealing with dementia: obstacles or opportunities?

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

Subscribe to our newsletter and stay up to date with the latest news.

: IMC First Acquisition of Porterhouse Medical Group
**Medical Communications** is a hot topic in today's market, and our team at **Candesic** is delighted to have supported Integrated Medhealth Communication ** (IMC)** through CDD of their first acquisition, **Porterhouse Medical Group**. We know the coming months will be a busy time for investors seeking platform opportunities in the Medical Affairs space, and Candesic is here to help navigate these waters having built our expertise in the second though projects on **Blue Latitude, Carling, Envision, Fishawack, IMC, Lucid, Signature, Xendo** , among many others.

: Cancer the forgotten ‘C’ of the Covid crisis
In the UK and across the globe, cancer care has been on hold as health systems struggle with the immediate challenge of Covid-19. As services take the first tentative steps towards reopening, Dr Michelle Tempest, Partner at Candesic and Dr Joe Taylor, Principal at Candesic, examine what measures need to be put in place to ensure safe and timely treatment for patients.

: MWE Healthcare Private Equity Symposium
Candesic's Dr Michelle Tempest has been invited to be the panelist at the European Healthcare Private Equity Symposium organised by _McDermott Will & Emery_. Where do the opportunities exist in this ever-changing world?